AboutSign In

lecanemab

Product

FDA-approved anti-amyloid monoclonal antibody for early Alzheimer's disease, marketed as Leqembi

3 stories

01
health22d ago

Blood Test Identifies Dementia Risk in Women 25 Years Before Symptoms Emerge

9 min read
02
health22d ago

Blood Tests Show Promise for Early Alzheimer's Detection

9 min read
03
health23d ago

Simple Blood Test Can Predict Dementia 25 Years in Advance

8 min read